Cleanser — Supplier Qualification Guide

Key Technical Parameters #

Qualifying a cleanser supplier isn’t about auditing a factory tour — it’s about interrogating the raw material chain that determines whether your finished formula is consistent, safe, and defensible in EU or US markets. The brand segments that feel this most acutely are those running sensitive-skin or microbiome-friendly claims, where a single surfactant lot with elevated 1,4-dioxane or inconsistent EO chain distribution can quietly invalidate the positioning. Our incoming inspection protocol (internally logged under the RM-QC-04 procedure) covers 23 material parameters across surfactant, emollient, and preservative inputs — and the failure rate on first-submission COAs from new suppliers runs higher than most brand partners expect. What follows is a working framework for what to demand, what to verify, and what disqualifies a supplier before you spend a dollar on pilot batches.

COA Field Requirements: What a Cleanser Supplier’s Documentation Must Actually Contain #

A COA that lists “appearance: clear liquid, pass” and three other fields is not a COA. We see this from mid-tier raw material distributors regularly — especially on commodity surfactant grades — and it’s the first thing we flag in our supplier onboarding review.

For a primary surfactant like sodium lauroyl methyl isethionate (SLMI) or sodium cocoyl glutamate, a qualified COA should include, at minimum: active matter content (%), free fatty acid content (%), pH of a 10% aqueous solution, colour on the APHA or Hazen scale, and heavy metal limits (lead, arsenic, cadmium). For ethoxylated surfactants — SLS, SLES, and polysorbates — the COA must also include residual 1,4-dioxane quantification. Per EU Cosmetics Regulation 1223/2009, 1,4-dioxane is not a listed restricted substance with a numeric limit, but the SCCS has flagged it as a process contaminant of concern, and SCCS Scientific Opinion guidance references a margin-of-safety framework that effectively pressures suppliers to demonstrate sub-10 ppm levels. In practice, we won’t accept ethoxylated surfactant lots above 8 ppm 1,4-dioxane regardless of market destination.

The other field brands consistently underestimate on COAs: microbial content for raw materials. Total aerobic count should be declared, not left blank. Blank means the supplier didn’t test — or doesn’t want you to see the result.

The traceability row matters more than it looks. We’ve had surfactant lots that passed all chemical parameters but, when traced back to the manufacturing site, originated from a secondary processor we hadn’t approved. That’s a supply chain audit problem, not a chemistry problem — but it creates regulatory exposure if you’re selling into the EU or running a China NMPA registration where raw material sourcing is audited during inspection.

Root Cause Analysis: Why Cleanser Raw Material Failures Happen and What They Tell You #

This is the section most qualification frameworks skip. COA compliance is a snapshot. What you actually need to understand is the mechanism behind failure — because the same root cause tends to repeat.

Scenario 1: Surfactant active matter drift across lots

We had a mid-2023 qualification run with a new sodium coco-sulfate supplier — 6 incoming lots over four months. Active matter spec was declared at 92% minimum, and lots 1 through 4 landed between 91.8% and 93.1%. Lots 5 and 6 came in at 89.3% and 88.7%. No deviation notice from the supplier. When we reformulated at the 89% input level, foam density in the finished cleanser dropped measurably and viscosity in the gel system shifted enough to affect the consumer texture call. The mechanism: active matter drift is almost always caused by inconsistent drying in the sulfonation/neutralisation process, particularly during seasonal humidity changes at the manufacturing site. What you’d check: ask the supplier for lot-to-lot active matter data across the prior 12 months, not just the most recent COA. A supplier who only provides the last lot is hiding something or doesn’t track it.

Scenario 2: pH excursion in amino acid surfactant lots

Amino acid-based surfactants — glutamates, sarcosinates — are pH-sensitive in storage. We’ve seen sodium cocoyl glycinate arrive at declared pH 6.5 (10% solution) and, after 8 weeks in storage at 30°C in HDPE drums, drift to pH 5.1. At pH below 5.5, these materials begin hydrolysing, releasing free fatty acid that causes cloudiness and a rancid off-note in the finished formula. Our protocol now requires re-testing pH on any amino acid lot that’s been in our warehouse longer than 6 weeks before it enters a production batch. The fix isn’t a different supplier — it’s tighter storage conditions and a re-test gate. But a supplier whose drumming or storage practice accelerates this drift is a risk multiplier.

Scenario 3: Polyglyceryl emulsifier inconsistency in cleansing balm inputs

For oil-cleansing formats that use polyglyceryl-3 diisostearate or polyglyceryl-4 oleate as the primary self-emulsifying component, HLB consistency lot-to-lot is the qualification variable that brands rarely ask about but we always push. The HLB value of polyglyceryl emulsifiers is not a fixed constant — it shifts with the degree of polymerisation achieved in synthesis, and this isn’t always tightly controlled at commodity grades. Across 11 incoming lots from three suppliers over roughly 18 months (tracked in our emulsifier variance log), we found HLB spread of ±0.8 units within the same grade designation from one supplier. That’s enough to shift phase inversion temperature by several degrees in a cleansing balm. The consequence: a formula that self-emulsifies cleanly at 37°C in the lab fails to rinse clearly at 20°C tap water. Consumers see a greasy film. The brand gets returns. We’re still not entirely sure whether the variance is seasonal or tied to feedstock sourcing — our current approach is to run a quick phase inversion check on every polyglyceryl lot before it clears the AVL gate, but it’s not a perfectly elegant solution.

Does a Third-Party Test Report Replace the Supplier’s COA? #

Short answer: no, and the distinction matters legally.

A third-party test report confirms specific parameters at the time of the test — useful for spot-checking or dispute resolution. The supplier’s COA is a declaration of conformance tied to the specific lot, signed under the supplier’s quality management system. Under FDA Cosmetics Guidelines, ingredient suppliers bear responsibility for accuracy of supplied specifications, and for EU product responsible persons, the Technical Dossier must reference raw material specifications from the declared supplier — not a generic third-party test run on a different lot. Third-party testing is a verification tool in our incoming QC stack. It doesn’t substitute for a proper COA or eliminate the need for supplier audits. For brands registering with NMPA Cosmetic Regulation in China, raw material documentation requirements are explicit: supplier-issued quality specifications are mandatory, and third-party reports alone are insufficient for registration dossier purposes.

Formulation Notes for Brand Partners #

When you brief us on a new cleanser SKU, the first question isn’t about texture or fragrance — it’s about the raw material tier you’re prepared to work with. This changes the qualification burden significantly. A cost-optimised cleanser using commodity SLES and cocamidopropyl betaine has a different supplier landscape than a microbiome-friendly format using fermented amino acid surfactants from a single-origin supplier in Japan.

The most common brief mistake: brands specify a named raw material — often because they’ve seen it on a competitor’s INCI list — without knowing which supplier grade or specification was used. We’ve run briefs where the requested material had three commercially available grades differing in active matter, residual solvent profile, and country of origin, each with different qualification histories in our cleanser formulation program. We push back on “use ingredient X” briefs and ask instead: what performance outcome does that ingredient deliver, and is there a supplier-qualified alternative that gets you there with a shorter lead time?

For a new cleanser development involving novel surfactants or unapproved raw material sources, realistic timeline expectations are: lab samples in 2–3 weeks, accelerated stability (40°C/75% RH, ICH Q1A-referenced conditions) running 4–8 weeks, and 24-month real-time stability initiated concurrently with accelerated testing. If your launch timeline requires skipping the accelerated stability gate, that is a conversation we need to have before pilot, not after.

For brands building a barrier-repair or sensitive-skin positioning on their cleanser, raw material qualification depth needs to match the claim. A “dermatologist-tested” call-out with a surfactant supplier who can’t produce lot-level ZEIN test data is a liability waiting to surface.

Frequently Asked Questions #

Our supplier sends a COA with every shipment — isn’t that enough?
A COA is the starting point, not the finish line. What matters is whether the parameters declared match your finished formula’s critical inputs, and whether the supplier’s internal test methods are equivalent to yours. We routinely see COAs that declare pH but omit the test temperature, which makes the number unverifiable — a 10% SLES solution reads differently at 20°C versus 25°C.

Which markets have the most demanding raw material documentation requirements for cleansers?
EU is the most structured, driven by EU Cosmetics Regulation 1223/2009 and the requirement for a safety assessment that explicitly references raw material purity specifications. China NMPA follows close behind for registered products. The US FDA framework is less prescriptive on raw material documentation at the point of import, but that will not protect you if an FDA adverse event investigation traces back to a contaminated ingredient lot.

What’s actually the most common reason a surfactant lot fails incoming inspection?
Active matter content out of spec — specifically, below the declared minimum. It happens more with liquid surfactant concentrates than with dried/powder grades, because dilution errors or moisture pick-up during storage aren’t always visible. Three out of roughly every 20 incoming surfactant lots we’ve inspected over the past two years have required hold or return on active matter grounds. The second most common failure is pH excursion on amino acid surfactant grades, as described above.

What’s the MOQ for a cleanser development if we’re using our own approved supplier?
Pilot batches run at 50–100 kg, depending on format. Production MOQ is typically 500 kg per SKU, though this depends on packaging format and filling line allocation. Timeline from finalised formula to first production batch is approximately 12–16 weeks when all raw materials are pre-qualified. If your supplier hasn’t previously been used in our production runs, add 4–6 weeks for our incoming qualification process.

Should we ask for clinical data from our surfactant supplier?
It depends on what claim you’re trying to support. Generic “mild” or “gentle” positioning doesn’t require clinical input from the raw material supplier — product-level testing covers it. But if you’re building an evidence-based claim around barrier preservation or microbiome compatibility at the ingredient level, supplier clinical data becomes relevant. A 2022 split-face, randomised controlled trial (n=40, 8 weeks) on a commercial sodium lauroyl glutamate-based cleanser formulation demonstrated a 23% reduction in TEWL versus an SLS-containing benchmark — that kind of supplier-generated study is worth requesting, because it underpins your finished product positioning. Whether the supplier will share it — and under what conditions — is a commercial negotiation.

---

Have a product concept in mind? Contact our formulation team to request a complimentary brief review.